| Christopher J Ciccone, MD | |
|
4125 Ironbound Rd, Suite 200, Williamsburg, VA 23188-2666 | |
| (757) 345-2829 | |
| (757) 345-0644 |
| Full Name | Christopher J Ciccone |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 4125 Ironbound Rd, Williamsburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659377356 | NPI | - | NPPES |
| 080091377 | Other | VA | RAILROAD MEDICARE |
| 5626072 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101052863 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Home Care Services-williamsburg | Williamsburg, VA | Home health agency |
| Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tidewater Physicians Multispecialty Group Pc | 2860398526 | 246 |
News Archive
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
By changing the behavior of certain cells within human blood vessels, Cornell University researchers have discovered important clues as to the underlying causes of atherosclerosis - a discovery researchers hope can lead to more targeted drug therapies for the prevention of the disease.
The Associated Press: South Africa is attempting to prepare its emergency services in case of a disaster at the World Cup, which begins next week. "But the public system won't have to cope alone, the chief medical officer for local tournament organizers said in an interview this week. Dr. Victor Ramathesele outlined plans for what he said would be unprecedented coordination between the public system, the military and the private sector in case of emergency during Africa's first World Cup."
The gene therapy market has had limited success with products during the clinical development process. Due to toxicological complications and poor therapy efficacy, healthcare authorities have suspended several gene therapy trials worldwide.
Porvair Sciences has announced that it will officially launch Chromatrap®96 HT – an innovative 96-well chromatin immunoprecipitation (ChIP) assay plate at Epigenomics of Common Diseases (Wellcome Trust, Cambridge, UK) from 7th-10th November 2013.
› Verified 3 days ago
| Entity Name | Tidewater Physicians Multispecialty Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902848294 PECOS PAC ID: 2860398526 Enrollment ID: O20031211000980 |
News Archive
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
By changing the behavior of certain cells within human blood vessels, Cornell University researchers have discovered important clues as to the underlying causes of atherosclerosis - a discovery researchers hope can lead to more targeted drug therapies for the prevention of the disease.
The Associated Press: South Africa is attempting to prepare its emergency services in case of a disaster at the World Cup, which begins next week. "But the public system won't have to cope alone, the chief medical officer for local tournament organizers said in an interview this week. Dr. Victor Ramathesele outlined plans for what he said would be unprecedented coordination between the public system, the military and the private sector in case of emergency during Africa's first World Cup."
The gene therapy market has had limited success with products during the clinical development process. Due to toxicological complications and poor therapy efficacy, healthcare authorities have suspended several gene therapy trials worldwide.
Porvair Sciences has announced that it will officially launch Chromatrap®96 HT – an innovative 96-well chromatin immunoprecipitation (ChIP) assay plate at Epigenomics of Common Diseases (Wellcome Trust, Cambridge, UK) from 7th-10th November 2013.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher J Ciccone, MD 860 Omni Blvd Ste 101, Newport News, VA 23606-4430 Ph: (757) 232-8769 | Christopher J Ciccone, MD 4125 Ironbound Rd, Suite 200, Williamsburg, VA 23188-2666 Ph: (757) 345-2829 |
News Archive
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.
By changing the behavior of certain cells within human blood vessels, Cornell University researchers have discovered important clues as to the underlying causes of atherosclerosis - a discovery researchers hope can lead to more targeted drug therapies for the prevention of the disease.
The Associated Press: South Africa is attempting to prepare its emergency services in case of a disaster at the World Cup, which begins next week. "But the public system won't have to cope alone, the chief medical officer for local tournament organizers said in an interview this week. Dr. Victor Ramathesele outlined plans for what he said would be unprecedented coordination between the public system, the military and the private sector in case of emergency during Africa's first World Cup."
The gene therapy market has had limited success with products during the clinical development process. Due to toxicological complications and poor therapy efficacy, healthcare authorities have suspended several gene therapy trials worldwide.
Porvair Sciences has announced that it will officially launch Chromatrap®96 HT – an innovative 96-well chromatin immunoprecipitation (ChIP) assay plate at Epigenomics of Common Diseases (Wellcome Trust, Cambridge, UK) from 7th-10th November 2013.
› Verified 3 days ago
Richard David Bagnall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Kings Way, Suite 1400, Williamsburg, VA 23185 Phone: 757-345-2555 Fax: 757-345-0366 | |
Dr. Shane H Peng, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Sentara Cir, Ste 450, Williamsburg, VA 23188 Phone: 757-345-4614 Fax: 757-345-4601 | |
Dr. Jamie Leigh Rygielski, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4374 New Town Ave Ste 200, Williamsburg, VA 23188 Phone: 757-984-6110 | |
Michelle Brodasky Covili, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 477 Mclaws Cir Ste 1, Williamsburg, VA 23185 Phone: 757-984-9650 Fax: 757-510-9232 | |
Mrs. Barbara Leigh Route, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4125 Ironbound Rd Ste 200, Williamsburg, VA 23188 Phone: 757-345-2829 | |
Bruce Mayer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7151 Richmond Rd Ste 403, Williamsburg, VA 23188 Phone: 757-566-2045 Fax: 757-741-2735 | |
Gregory J. Biernacki, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4374 New Town Ave, Suite 200, Williamsburg, VA 23188 Phone: 757-220-2795 Fax: 757-259-8797 |